Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sangita Baxi"'
Publikováno v:
Systematic Reviews, Vol 12, Iss 1, Pp 1-7 (2023)
Abstract Background Enhanced recovery after surgery (ERAS) interventions aim to improve patient outcomes. Vascular surgery patients have unique requirements and it is unclear which ERAS interventions are supported by an evidence base. Methods We cond
Externí odkaz:
https://doaj.org/article/c535efcfde6e402ea3a67a47371aa576
Publikováno v:
Medical Care. 61:353-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aab45640fd5b6863ba9d80f4c29cecce
https://doi.org/10.1097/mlr.0000000000001853
https://doi.org/10.1097/mlr.0000000000001853
Autor:
Sangita Baxi, Irineo Cabreros, Lisa S. Meredith, Stephanie Brooks Holliday, Jose Martinez, Tepring Piquado
Publikováno v:
Journal of Head Trauma Rehabilitation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbc8137b0789f2fd72095da09fb62c65
https://doi.org/10.1097/htr.0000000000000828
https://doi.org/10.1097/htr.0000000000000828
Autor:
Hengmiao, Cheng, Sajiv K, Nair, Brion W, Murray, Chau, Almaden, Simon, Bailey, Sangita, Baxi, Doug, Behenna, Sujin, Cho-Schultz, Deepak, Dalvie, Dac M, Dinh, Martin P, Edwards, Jun Li, Feng, Rose Ann, Ferre, Ketan S, Gajiwala, Michelle D, Hemkens, Amy, Jackson-Fisher, Mehran, Jalaie, Ted O, Johnson, Robert S, Kania, Susan, Kephart, Jennifer, Lafontaine, Beth, Lunney, Kevin K-C, Liu, Zhengyu, Liu, Jean, Matthews, Asako, Nagata, Sherry, Niessen, Martha A, Ornelas, Suvi T M, Orr, Mason, Pairish, Simon, Planken, Shijian, Ren, Daniel, Richter, Kevin, Ryan, Neal, Sach, Hong, Shen, Tod, Smeal, Jim, Solowiej, Scott, Sutton, Khanh, Tran, Elaine, Tseng, William, Vernier, Marlena, Walls, Shuiwang, Wang, Scott L, Weinrich, Shuibo, Xin, Haiwei, Xu, Min-Jean, Yin, Michael, Zientek, Ru, Zhou, John C, Kath
Publikováno v:
Journal of medicinal chemistry. 59(5)
First generation EGFR TKIs (gefitinib, erlotinib) provide significant clinical benefit for NSCLC cancer patients with oncogenic EGFR mutations. Ultimately, these patients' disease progresses, often driven by a second-site mutation in the EGFR kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f69cf3e766e492ce164cc24ad82b59de
https://pubmed.ncbi.nlm.nih.gov/26756222
https://pubmed.ncbi.nlm.nih.gov/26756222